glp-1 receptor agonists and cancer risk in adults with obesity The effect of GLP-1R on the medical triad of obesity, diabetes, | Cancer and Metastasis Reviews Many adults stop GLP-1 therapy
Description
2014;129(25 Suppl 2):S10238
Indian Journal of Endocrinology and Metabolism 26 (5)
Highlights Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone produced by intestinal L cells through differential processing of the proglucagon (PG) gene [1]
These actions make GLP-1 agonists like semaglutide GLP-1 and Zepbound effective for weight loss
Additionally, further research is needed to explore the broader therapeutic potential of these agents in managing comorbidities such as cardiovascular disease, PCOS, CKD, MASH, and osteoarthritis
All rights reserved.
